Nanoscale Organization of TRAIL Trimers using DNA Origami to Promote Clustering of Death Receptor and Cancer Cell Apoptosis

被引:10
|
作者
Ma, Nana [1 ,2 ]
Cheng, Keman [1 ,2 ]
Feng, Qingqing [1 ,2 ]
Liu, Guangna [1 ,2 ]
Liang, Jie [1 ,2 ]
Ma, Xiaotu [1 ,2 ]
Chen, Zhiqiang [1 ,2 ]
Lu, Yichao [1 ,2 ]
Wang, Xinwei [1 ,2 ]
He, Wei [3 ]
Xu, Hu [3 ]
Wu, Shan [3 ]
Zou, Jiajia [4 ]
Shi, Quanwei [4 ]
Nie, Guangjun [1 ,2 ,5 ]
Zhao, Xiao [1 ,2 ,5 ,6 ]
机构
[1] Natl Ctr Nanosci & Technol China, CAS Key Lab Biomed Effects Nanomat & Nanosafety, 11 Beiyitiao, Beijing 100190, Peoples R China
[2] Natl Ctr Nanosci & Technol China, CAS Ctr Excellence Nanosci, 11 Beiyitiao, Beijing 100190, Peoples R China
[3] Hubei Univ, State Key Lab Biocatalysis & Enzyme Engn, Hubei Collaborat Innovat Ctr Green Transformat Bio, Hubei Key Lab Ind Biotechnol,Sch Life Sci, Wuhan 430062, Hubei, Peoples R China
[4] Beijing Intell Nanomed, 9 Chengwan St, Beijing 100000, Peoples R China
[5] Univ Chinese Acad Sci, Ctr Mat Sci & Optoelect Engn, Beijing 100049, Peoples R China
[6] Chinese Acad Sci, Inst Genet & Dev Biol, IGDB NCNST Joint Res Ctr, Beijing 100101, Peoples R China
基金
中国国家自然科学基金; 北京市自然科学基金; 国家重点研发计划;
关键词
death receptors; DNA origami; interligand distance; nanoscale organization; TRAIL trimers; tumor therapy; STRUCTURAL BASIS; AMG; 655; LIGAND; CONATUMUMAB; APO2L/TRAIL; COMBINATION;
D O I
10.1002/smll.202206160
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Through inducing death receptor (DR) clustering to activate downstream signaling, tumor necrosis factor related apoptosis inducing ligand (TRAIL) trimers trigger apoptosis of tumor cells. However, the poor agonistic activity of current TRAIL-based therapeutics limits their antitumor efficiency. The nanoscale spatial organization of TRAIL trimers at different interligand distances is still challenging, which is essential for the understanding of interaction pattern between TRAIL and DR. In this study, a flat rectangular DNA origami is employed as display scaffold, and an "engraving-printing" strategy is developed to rapidly decorate three TRAIL monomers onto its surface to form DNA-TRAIL3 trimer (DNA origami with surface decoration of three TRAIL monomers). With the spatial addressability of DNA origami, the interligand distances are precisely controlled from 15 to 60 nm. Through comparing the receptor affinity, agonistic activity and cytotoxicity of these DNA-TRAIL3 trimers, it is found that approximate to 40 nm is the critical interligand distance of DNA-TRAIL3 trimers to induce death receptor clustering and the resulting apoptosis.Finally, a hypothetical "active unit" model is proposed for the DR5 clustering induced by DNA-TRAIL3 trimers.
引用
收藏
页数:12
相关论文
共 29 条
  • [21] Luteolin sensitizes human liver cancer cells to TRAIL-induced apoptosis via autophagy and JNK-mediated death receptor 5 upregulation
    Nazim, Uddin Md.
    Park, Sang-Youel
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (02) : 665 - 672
  • [22] Epigallocatechin-3-Gallate Induces Apoptosis as a TRAIL Sensitizer via Activation of Caspase 8 and Death Receptor 5 in Human Colon Cancer Cells
    Kwon, Oh Sung
    Jung, Ji Hoon
    Shin, Eun Ah
    Park, Ji Eon
    Park, Woon Yi
    Kim, Sung-Hoon
    BIOMEDICINES, 2020, 8 (04)
  • [23] Aldose reductase inhibition enhances TRAIL-induced human colon cancer cell apoptosis through AKT/FOXO3a-dependent upregulation of death receptors
    Shoeb, Mohammad
    Ramana, Kota V.
    Srivastava, Satish K.
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 63 : 280 - 290
  • [24] Activation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor gene expression following DNA demethylation in placental choriocarcinoma and transformed cell lines
    Wu, Pan-Hong
    Chen, Xue-Mei
    Liu, Xue-Qing
    He, Jun-Lin
    Feng, Qian
    Lan, Xi
    Zhang, Xue
    Geng, Yan-Qing
    Wang, Ying-Xiong
    Ding, Yu-Bin
    REPRODUCTION FERTILITY AND DEVELOPMENT, 2016, 28 (11) : 1844 - 1853
  • [25] Tangeretin sensitises human lung cancer cells to TRAIL-induced apoptosis via ROS-JNK/ERK-CHOP pathwaymediated up-regulation of death receptor 5
    Liu, Xi
    Chen, Lei
    Liu, Yang
    Zhang, Tao
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (01) : 17 - 29
  • [26] Enhanced extrinsic apoptosis of therapy-induced senescent cancer cells using a death receptor 5 (DR5) selective agonist
    Soto-Gamez, Abel
    Wang, Yizhou
    Zhou, Xinyu
    Seras, Lorina
    Quax, Wim
    Demaria, Marco
    CANCER LETTERS, 2022, 525 : 67 - 75
  • [27] RETRACTED: Dasatinib promotes TRAIL-mediated apoptosis by upregulating CHOP-dependent death receptor 5 in gastric cancer (Retracted article. See vol. 13, pg. 798, 2023)
    Wang, Xiaona
    Xue, Qiang
    Wu, Liangliang
    Wang, Baogui
    Liang, Han
    FEBS OPEN BIO, 2018, 8 (05): : 732 - 742
  • [28] Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non-Small-Cell Lung Cancer
    von Pawel, Joachim
    Harvey, Jimmie H.
    Spigel, David R.
    Dediu, Mircea
    Reck, Martin
    Cebotaru, Cristina L.
    Humphreys, Robin C.
    Gribbin, Matthew J.
    Fox, Norma Lynn
    Camidge, D. Ross
    CLINICAL LUNG CANCER, 2014, 15 (03) : 188 - +
  • [29] Acrolein sensitizes human renal cancer Caki cells to TRAIL-induced apoptosis via ROS-mediated up-regulation of death receptor-5 (DR5) and down-regulation of Bcl-2
    Yang, Eun Sun
    Woo, Seon Min
    Choi, Kyeong Sook
    Kwon, Taeg Kyu
    EXPERIMENTAL CELL RESEARCH, 2011, 317 (18) : 2592 - 2601